Recent advances of pyrrolopyridines derivatives: a patent and literature review
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances of pyrrolopyridines derivatives: a patent and literature review
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 27, Issue 5, Pages 591-606
Publisher
Informa UK Limited
Online
2017-01-09
DOI
10.1080/13543776.2017.1280465
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors
- (2016) Wufu Zhu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 1-Sulfonyl-6-Piperazinyl-7-Azaindoles as potent and pseudo-selective 5-HT 6 receptor antagonists
- (2016) Charles-Henry Fabritius et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors
- (2016) Qidong Tang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and evaluation of a series of 4-azaindole-containing p21-activated kinase-1 inhibitors
- (2016) Wendy Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and biological evaluation of pyrrolo[2,3- b ]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA
- (2016) Suresh Narva et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors
- (2015) Michael J. Boyd et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 6-(Azaindol-2-yl)pyridine-3-sulfonamides as potent and selective inhibitors targeting hepatitis C virus NS4B
- (2015) Guangming Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of 7-azaindole derivatives as potent Orai inhibitors showing efficacy in a preclinical model of asthma
- (2015) Cristina Esteve et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and Evaluation of 1H-Pyrrolo[2,3-b]pyridine Derivatives as Novel Immunomodulators Targeting Janus Kinase 3
- (2015) Yutaka Nakajima et al. CHEMICAL & PHARMACEUTICAL BULLETIN
- Cell-Based Biological Evaluation of a New Bisamide FMS Kinase Inhibitor Possessing Pyrrolo[3,2-c]pyridine Scaffold
- (2014) Mohammed I. El-Gamal et al. ARCHIV DER PHARMAZIE
- Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore
- (2014) Hossein Razavi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists III: The role of a hydrogen-bond acceptor in long receptor residence times
- (2014) Juan Antonio Alonso et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Structure–activity relationships (SAR) and structure–kinetic relationships (SKR) of bicyclic heteroaromatic acetic acids as potent CRTh2 antagonists II: Lead optimization
- (2014) Juan Antonio Alonso et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Anticancer activity of HS-527, a novel inhibitor targeting PI3-kinase in human pancreatic cancer cells
- (2014) Ye-Lim Ryu et al. CANCER LETTERS
- Discovery of small molecular inhibitors targeting HIV-1 gp120–CD4 interaction drived from BMS-378806
- (2014) Tao Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development and Biological Evaluation of Potent and Selective c-KITD816V Inhibitors
- (2014) Soyoung Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Novel, First-in-Class, Orally Bioavailable Azaindole Inhibitor (VX-787) of Influenza PB2
- (2014) Michael P. Clark et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Azaindole Framework in the Design of Kinase Inhibitors
- (2014) Jean-Yves Mérour et al. MOLECULES
- Inhibitory Effects of a New 1H-Pyrrolo[3,2-c]pyridine Derivative, KIST101029, on Activator Protein-1 Activity and Neoplastic Cell Transformation Induced by Insulin-Like Growth Factor-1
- (2013) Hyo Jeong Yun et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Discovery and characterization of NVP-QAV680, a potent and selective CRTh2 receptor antagonist suitable for clinical testing in allergic diseases
- (2013) David A. Sandham et al. BIOORGANIC & MEDICINAL CHEMISTRY
- 7-Azaindole-1-carboxamides as a new class of PARP-1 inhibitors
- (2013) Raffaella Cincinelli et al. BIOORGANIC & MEDICINAL CHEMISTRY
- N-substituted azaindoles as potent inhibitors of Cdc7 kinase
- (2013) Marian C. Bryan et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: Wild type and mutant (L1196M) active compounds with unique binding mode
- (2013) Venkateshwar Rao Gummadi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer
- (2013) Ju Hyeon Seo et al. CANCER LETTERS
- The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use
- (2013) Silvy da Rocha Dias et al. EUROPEAN JOURNAL OF CANCER
- Insight into the toxic effects of cis-dichloridoplatinum(II) complexes containing 7-azaindole halogeno derivatives in tumor cells
- (2013) Tereza Muchova et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Novel 1H-Pyrrolo[2,3-b]pyridine Derivative Nortopsentin Analogues: Synthesis and Antitumor Activity in Peritoneal Mesothelioma Experimental Models
- (2013) Anna Carbone et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3
- (2013) Val S. Goodfellow et al. JOURNAL OF MEDICINAL CHEMISTRY
- Azaindole-Based Inhibitors of Cdc7 Kinase: Impact of the Pre-DFG Residue, Val 195
- (2013) Yunsong Tong et al. ACS Medicinal Chemistry Letters
- Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells
- (2012) Chung-Pu Wu et al. BIOCHEMICAL PHARMACOLOGY
- Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines. Part 2
- (2012) Myung-Ho Jung et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibitors of HIV-1 attachment. Part 10. The discovery and structure–activity relationships of 4-azaindole cores
- (2012) Tao Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and Synthesis of an Anticancer Diarylurea Derivative with Multiple-Kinase Inhibitory Effect
- (2012) Mohammed I. El-Gamal et al. BULLETIN OF THE KOREAN CHEMICAL SOCIETY
- Vemurafenib in Patients With BRAF V600E Mutation–Positive Advanced Melanoma
- (2012) Marcus C. Ravnan et al. CLINICAL THERAPEUTICS
- Design, Synthesis, and Evaluation of 3,5-Disubstituted 7-Azaindoles as Trk Inhibitors with Anticancer and Antiangiogenic Activities
- (2012) Seunghee Hong et al. JOURNAL OF MEDICINAL CHEMISTRY
- FMS Kinase Inhibitors: Current Status and Future Prospects
- (2012) Mohammed I. El-Gamal et al. MEDICINAL RESEARCH REVIEWS
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with Vemurafenib
- (2012) Jeffrey A. Sosman et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Response of Cancers to BRAF Inhibition Underscores the Importance of Cancer Systems Biology
- (2012) E. C. Stites Science Signaling
- Design, synthesis, and antiproliferative activity of new 1H-pyrrolo[3,2-c]pyridine derivatives against melanoma cell lines
- (2011) Mohammed I. El-Gamal et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Diffuse malignant peritoneal mesothelioma: Systematic review of clinical management and biological research
- (2011) Dario Baratti et al. JOURNAL OF SURGICAL ONCOLOGY
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery of a new potent bisamide FMS kinase inhibitor
- (2010) Mohammed I. El-Gamal et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of new azaindole-based PI3Kα inhibitors: Apoptotic and antiangiogenic effect on cancer cells
- (2010) Seunghee Hong et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started